Heavy alcohol consumption and risk of atrial fibrillation: The circulatory risk in communities study (circs)

Circulation Journal

Volumn 78, Issue 4, 2014, Pages 955-961

  Sano, Fumihiko ^a,b   Ohira, Tetsuya ^a   Kitamura, Akihiko ^c   Imano, Hironori ^a   Cui, Renzhe ^a   Kiyama, Masahiko ^c   Okada, Takeo ^c   Yamagishi, Kazumasa ^d   Sankai, Tomoko ^d   Tanigawa, Takeshi ^e   Kario, Kazuomi ^b   Iso, Hiroyasu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Osaka Center for Cancer and Cardiovascular Diseases Prevention   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alcohol; Atrial fibrillation; Epidemiology; Risk factors

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; DISEASE SURVEILLANCE; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; RURAL POPULATION;

EID: 84897857136     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.cj-13-1387     Document Type: Article

References (43)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
2. Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA 1981; 245: 1540-1544.
3. Yamashita T. Recent mortality and morbidity rates of Japanese atrial fibrillation patients: Racial differences and risk stratifcation. Circ J 2013; 77: 864-868.
4. Pisters R, Lane DA, Marin F, Camm AJ, Lip GY. Stroke and throm-boembolism in atrial fibrillation: Systematic review of stroke risk factors and risk stratification schema. Circ J 2012; 76: 2289-2304.
5. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: The Framingham Heart Study. Circulation 2004; 110: 1042-1046.
6. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998; 98: 946-952.
7. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359-364.
8. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-988.
9. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.
10. Macfarlane PW, Murray H, Sattar N, Stott DJ, Ford I, Buckley B, et al. The incidence and risk factors for new onset atrial fibrillation in the PROSPER study. Europace 2011; 13: 634-639.
11. Watanabe H, Tanabe N, Watanabe T, Darbar D, Roden DM, Sasaki S, et al. Metabolic syndrome and risk of development of atrial fibril-lation: The Niigata preventive medicine study. Circulation 2008; 117: 1255-1260.
12. Watanabe H, Watanabe T, Sasaki S, Nagai K, Roden DM, Aizawa Y. Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study. Am Heart J 2009; 158: 629-636.
13. Djoussé L, Levy D, Benjamin EJ, Blease SJ, Russ A, Larson MG, et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol 2004; 93: 710-713.
14. Rich EC, Siebold C, Campion B. Alcohol-related acute atrial fbril-lation: A case-control study and review of 40 patients. Arch Intern Med 1985; 145: 830-833.
15. Koskinen P, Kupari M, Leinonen H, Luomanmäki K. Alcohol and new onset atrial fibrillation: A case-control study of a current series. Br Heart J 1987; 57: 468-473.
16. Ruigómez A, Johansson S, Wallander MA, Rodríguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002; 55: 358-363.
17. Frost L, Vestergaard P. Alcohol and risk of atrial fibrillation or fut-ter: A cohort study. Arch Intern Med 2004; 164: 1993-1998.
18. Koskinen P. A 4-year prospective follow-up study of the role of alcohol in recurrences of atrial fibrillation. J Intern Med 1991; 230: 423-426.
19. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-2461.
20. Conen D, Tedrow UB, Cook NR, Moorthy MV, Buring JE, Albert CM. Alcohol consumption and risk of incident atrial fibrillation in women. JAMA 2008; 300: 2489-2496.
21. Mukamal KJ, Tolstrup JS, Friberg J, Jensen G, Grønbaek M. Alcohol consumption and risk of atrial fibrillation in men and women: The Copenhagen City Heart Study. Circulation 2005; 112: 1736-1742.
22. Kodama S, Saito K, Tanaka S, Horikawa C, Saito A, Heianza Y, et al. Alcohol consumption and risk of atrial fibrillation: A meta-analysis. J Am Coll Cardiol 2011; 57: 427-436.
23. O'Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: The razor-sharp double-edged sword. J Am Coll Cardiol 2007; 50: 1009-1014.
24. Menezes AR, Lavie CJ, Dinicolantonio JJ, O'Keefe J, Morin DP, Khatib S, et al. Atrial fibrillation in the 21st century: A current understanding of risk factors and primary prevention strategies. Mayo Clin Proc 2013; 88: 394-409.
25. Goedde HW, Agarwal DP. Polymorphism of aldehyde dehydroge-nase and alcohol sensitivity. Enzyme 1987; 37: 29-44.
26. Shimamoto T, Komachi Y, Inada H, Doi M, Iso H, Sato S, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989; 79: 503-515.
27. Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T, et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003: The Akita-Osaka study. J Am Coll Cardiol 2008; 52: 71-79.
28. Imano H, Kitamura A, Sato S, Kiyama M, Ohira T, Yamagishi K, et al. Trends for blood pressure and its contribution to stroke incidence in the middle-aged Japanese population: The Circulatory Risk in Communities Study (CIRCS). Stroke 2009; 40: 1571-1577.
29. International guidelines for ethical review of epidemiological studies. Law Med Health Care 1991; 19: 247-258.
30. De Bacquer D, De Backer G, Kornitzer M, Blackburn H. Prognostic value of ECG fndings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart 1998; 80: 570-577.
31. Nakamura M, Sato S, Shimamoto T. Improvement in Japanese clinical laboratory measurements of total cholesterol and HDL-choles-terol by the US Cholesterol Reference Method Laboratory Network. J Atheroscler Thromb 2003; 10: 145-153.
32. Iso H, Kitamura A, Shimamoto T, Sankai T, Naito Y, Sato S, et al. Alcohol intake and the risk of cardiovascular disease in middle-aged Japanese men. Stroke 1995; 26: 767-773.
33. Kitamura A. Trends in alcohol intake among urban and rural Japanese populations. Nihon Koshu Eisei Zasshi 1996; 43: 142-152 (in Japanese).
34. Denison H, Jern S, Jagenburg R, Wendestam C, Wallerstedt S. Infu-ence of increased adrenergic activity and magnesium depletion on cardiac rhythm in alcohol withdrawal. Br Heart J 1994; 72: 554-560.
35. Mäki T, Toivonen L, Koskinen P, Näveri H, Härkönen M, Leinonen H. Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation. Am J Cardiol 1998; 82: 317-322.
36. Koskinen P, Virolainen J, Kupari M. Acute alcohol intake decreases short-term heart rate variability in healthy subjects. Clin Sci 1994; 87: 225-230.
37. Rossinen J, Viitasalo M, Partanen J, Koskinen P, Kupari M, Nieminen MS. Effects of acute alcohol ingestion on heart rate variability in patients with documented coronary artery disease and stable angina pec-toris. Am J Cardiol 1997; 79: 487-491.
38. Marcus GM, Smith LM, Whiteman D, Tseng ZH, Badhwar N, Lee BK, et al. Alcohol intake is signifcantly associated with atrial futter in patients under 60 years of age and a shorter right atrial effective refractory period. Pacing Clin Electrophysiol 2008; 31: 266-272.
39. Gavazzi A, De Maria R, Parolini M, Porcu M. Alcohol abuse and dilated cardiomyopathy in men. Am J Cardiol 2000; 85: 1114-1118.
40. Zhang X, Li SY, Brown RA, Ren J. Ethanol and acetaldehyde in alcoholic cardiomyopathy: From bad to ugly en route to oxidative stress. Alcohol 2004; 32: 175-186.
41. Crabb DW, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc Nutr Soc 2004; 63: 49-63.
42. Pautassi RM, Camarini R, Quadros IM, Miczek KA, Israel Y. Genetic and environmental infuences on ethanol consumption: Perspectives from preclinical research. Alcohol Clin Exp Res 2010; 34: 976-987.
43. Lee KW, Yang Y, Scheinman MM. Atrial futter: A review of its history, mechanisms, clinical features, and current therapy. Curr Probl Cardiol 2005; 30: 121-167.